Substituted basic 2-aminotetralins
CA 1332834 C · Owner: Traber, Jorg · Inventors: Allen, George S.; Schohe, Rudolf; Traber, Jorg
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
For treatment of disorders of the central nervous system, the cardiovascular system or the intestinal tract the new substituted basic 2-aminotetralins of the formula in which, R1 represents hydrogen or alkyl R2 represents hydrogen, alkyl or acyl, and R3 represents quinuclidine or, a group of the formula -(CH2)a-R4, -CH2-CH=CH-(CH2)b-R4, -CH2-C?C-(CH2)b-R4 or , wherein, a denotes a number from 1 to 10 b denotes a number 0, 1, 2, 3 or 4, c denotes a number 0 1 or 2, d denotes a number 2 or 3, and X denotes oxygen, sulphur or NR5, and their salts.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Granted November 1, 1994. A Canadian patent filed before October 1, 1989 lasted 17 years from grant, so its term ended November 1, 2011.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.